Literature DB >> 28207857

Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0166415.].

Entities:  

Year:  2017        PMID： 28207857      PMCID： PMC5313219          DOI： 10.1371/journal.pone.0172775

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


Several of the grant numbers in the Funding section are listed incorrectly. The correct funding information is as follows: This research was supported by the Ministry of Science and Technology of China (2015CB964502, 2014CB964802), the National Natural Science Foundation of China (31371419), Science and Technology Commission of Shanghai Municipality (14DZ1900402). The publisher apologizes for the errors.
  1 in total

1.  An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.

Authors:  Jing Lu; Jin Cui; Xiaohang Li; Xin Wang; Yue Zhou; Wenjuan Yang; Ming Chen; Jian Zhao; Gang Pei
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.